Cyklx Solution/ Drops
NDC Package 87047-7852-2
Package Information
Cyklx (articaine hydrochloride) solution/ dropses is cYKLX is indicated for ocular surface anesthesia prior to ocular procedures and/or intraocular injections in adults and pediatric patients. This formulation utilizes a solution/ drops delivery system. Marketed by American Genomics, Llc, this product is identified by NDC 87047-7852 and is authorized under FDA application NDA218643.
Identification & Billing
- RxCUI: 2739743 - articaine 8 % Ophthalmic Solution
- RxCUI: 2739743 - articaine 80 MG/ML Ophthalmic Solution
- RxCUI: 2739743 - articaine (as articaine hydrochloride) 8 % Ophthalmic Solution
- RxCUI: 2739748 - Cyklx 8 % Ophthalmic Solution
- RxCUI: 2739748 - articaine 80 MG/ML Ophthalmic Solution [Cyklx]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87047 - American Genomics, Llc
- 87047-7852 - Cyklx
- 87047-7852-2 - 2 POUCH in 1 CARTON / 5 VIAL, SINGLE-DOSE in 1 POUCH / .4 mL in 1 VIAL, SINGLE-DOSE
- 87047-7852 - Cyklx
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (87047-7852). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87047-7852-2 identifies a specific commercial package of 2 pouch in 1 carton / 5 vial, single-dose in 1 pouch / .4 ml in 1 vial, single-dose of Cyklx, a human prescription drug labeled by American Genomics, Llc. This solution/ drops is formulated for ophthalmic use and contains articaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Genomics, Llc on April 02, 2026. The current certification is valid through December 31, 2026.
How is this American Genomics, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87047785202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.